NOTCH1 and head and neck squamous cell carcinoma: One example of a trial that seeks to determine patient response in a subgroup of individuals with molecular enrichment is NCT02649530; this study is intended to evaluate WNT974 as a treatment for HNSCC patients with NOTCH1 deficient tumors.